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Summary
The available data suggest that traditional Chinese acupuncture and some herbal products are efﬁ cacious for management of pain in patients 
with lower limb OA. Many herbal supplements are worthy of further study, particularly studies focused on potential mechanisms of action as 
either analgesic and/or anti-inﬂ ammatory agents. At the moment, these modalities deserve to be considered as part of a multidisciplinary 
approach to management of patients with symptomatic lower limb OA.
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Current recommendations for the management of patients 
with symptomatic osteoarthritis (OA) of the hips and/or 
knees emphasize a multidisciplinary approach focused on 
the reduction of pain, functional limitation and disability, 
as well as improvement in health-related quality of life.1–4
This multidisciplinary approach incorporates the use of 
non-pharmacologic modalities, including patient education, 
occupational and physical therapy, social support and weight 
loss, as well as pharmacologic therapies, including simple 
and opioid analgesics, non-steroidal anti-inﬂ ammatory drugs 
(NSAIDs) and injectable agents including glucocorticoids and 
hyaluronan preparations. In patients whose symptoms are 
not adequately controlled with this approach, attention has 
been directed recently towards the use of complementary 
and alternative therapies, including acupuncture and 
herbal preparations, either alone or in combination with 
background therapy.5,6 This review summarizes results 
of systematic reviews and our experience with the use of 
acupuncture and herbal compounds in patients with OA; 
the use of nutritional supplements, including vitamins, is 
reviewed elsewhere.7–9
Acupuncture
Ezzo and colleagues conducted a systematic review of 
controlled trials of acupuncture for knee OA published from 
1966 through 1999.10 A total of seven trials that included 393 
patients were included in the review; 3 trials used a sham 
acupuncture control group while 2 each used a physical 
therapy and waiting list control group. Outcomes included 
pain in all studies and physical function in six. Because 
of the numerous types of control groups and insufﬁ cient 
reporting of data in individual trials, the method of best-
evidence synthesis was used to qualitatively combine 
trials rather than a formal meta-analysis. The review found 
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strong evidence that acupuncture was more effective than 
sham acupuncture for relief of pain; however, there was 
inconclusive evidence that acupuncture was more effective 
than sham acupuncture for function. Similarly, there was 
inconclusive evidence that acupuncture was more effective 
than physical therapy for both pain and function. There was 
limited evidence, however, that acupuncture was more 
effective than a wait list control group for both pain and 
function. The authors suggested that future studies should 
deﬁ ne an optimal acupuncture treatment regimen and 
assess acupuncture in combination with other modalities.
White and colleagues conducted a systematic review 
of controlled trials of acupuncture published through June 
2006.11 This study included a total of 13 trials involving 2362 
patients; six of these 13 studies were published after the 
review by Ezzo and colleagues. Pain was measured with 
the WOMAC subscale in 8 studies and with a numerical 
rating scale and a Likert scale in study 3 and 2, respectively. 
Seven studies measured physical function with the WOMAC 
subscale. The meta-analysis pooled results from 5 studies 
including 1334 patients for short-term (14 weeks or less) 
pain relief; acupuncture was signiﬁ cantly superior to sham 
acupuncture: weighted mean difference = 1.54 units (95% 
conﬁ dence interval [CI] 0.49, 2.60) (Fig. 1A). The magnitude 
of the difference declined but remained signiﬁ cant even after 
exclusion of the results of an outlier study. There was also 
a signiﬁ cant short-term improvement in physical function 
of 4.32 units (95% CI 0.60, 8.05) that remained signiﬁ cant 
after exclusion of the same outlier study (Fig. 1B). Data 
pooled from 3 additional studies including 1178 patients 
also showed signiﬁ cant improvement in long-term (26 to 
52 weeks) pain and function. The authors concluded that 
adequate acupuncture is superior to sham acupuncture 
for treating chronic knee pain in patients with OA and is 
associated with a moderate effect size of similar magnitude 
to that of NSAIDs. 
We have demonstrated that traditional Chinese acu-
puncture is superior to both sham acupuncture and an 
education control as adjunctive therapy for patients with 
symptomatic knee OA;12 these data were included in the 
systematic review by White and colleagues cited above.11
As part of the protocol, data were collected from participants 
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who completed the 6-month trial on health care utilization 
during the study. Using these data, we found that traditional 
Chinese acupuncture was cost-effective compared to 
participation in an educational program modeled after The 
Arthritis Self-Help Course with an estimated cost of U.S. 
$30,000 per quality-adjusted life-year gained.13
Herbal compounds
Long and colleagues conducted a systematic review of 
randomized controlled trials (RCTs) of herbal medicines 
and plant extracts for OA through May 2000.14 They included 
12 trials that reported data on 10 different compounds and 
two systematic reviews, one each for topical capsaicin and 
Phytodolor (a ﬁ xed herbal formulation containing alcoholic 
extracts of Populus tremula, Fraxinus escelsior and 
Solidago virgaurea in a 3:1:1 ratio). The authors concluded 
that there was “moderately strong evidence” for efﬁ cacy 
of topical capsaicin cream and Phytodolor; “promising 
evidence” for avocado/soy bean unsaponiﬁ ables and Devil’s 
claw (Harpagophytum procumbens); and “weak evidence” 
for Articulin-F (an ayurvedic preparation), common stinging 
nettle, willow bark and Reumalex. The authors felt there 
was no compelling evidence in support of ginger extract, 
Eazmov (another ayurvedic preparation) or Gitadyl (an 
herbal preparation containing feverfew, American aspen 
and milfoil). 
A systematic review of RCTs of avocado/soy bean 
unsaponiﬁ ables (ASU) for OA was reported by Ernst.15 This 
review included four placebo-controlled trials published 
through April 2002. Three studies including 587 patients 
focused on symptomatic outcomes and found that patients 
randomized to ASU 300 mg once daily had improved 
outcomes and required less concomitant therapy with 
NSAIDs than patients randomized to placebo. One RCT 
including only 163 patients with hip OA focused on structural 
outcomes and failed to demonstrate a signiﬁ cant difference 
from placebo in change in joint space width over 2 years.16
These data suggest that ASU is effective as an adjunctive 
slow-acting symptomatic drug for OA that can lead to a 
decrease in NSAID usage.
A systematic review of trials of a nutriceutical supplement 
based on powdered freeze-dried New Zealand green-lipped 
mussel Perna canaliculus for arthritis was reported by Cobb 
and Ernst.17 This review included six RCTs published through 
February 2005; only two of these trials, however, included 
patients with OA. In one 3-month placebo-controlled RCT 
that included 38 OA patients awaiting joint surgery, there 
was no signiﬁ cant difference between treatment with mussel 
extract and placebo for global improvement. In another 
6-month placebo-controlled RCT that included 53 patients 
with knee OA, four of ten outcome measures signiﬁ cantly 
improved in patients taking the mussel extract compared 
to placebo, one signiﬁ cantly improved in patients taking 
placebo compared to the mussel extract, and there were 
no signiﬁ cant differences in the remaining ﬁ ve measures. 
These data suggest that there is little compelling evidence 
to support the use of this supplement in patients with OA. 
Another RCT compared Devil’s claw to diacerein in 
the treatment of patients with hip or knee OA.18 There 
was no signiﬁ cant difference in efﬁ cacy between the 
groups, although patients randomized to Devil’s claw were 
more likely to reduce or discontinue use of concomitant 
NSAID therapy and were less likely to report side effects, 
particularly diarrhea. Diacerein has been shown to be more 
efﬁ cacious than placebo and to have similar efﬁ cacy to 
NSAIDs in a systematic review of RCTs in patients with hip 
and/or knee OA.19
Another placebo-controlled RCT examined the efﬁ cacy 
of a ginger extract (Eurovita Holding, Karlslunde, Denmark) 
in 261 patients with knee OA.20 Patients randomized to 
the ginger extract were signiﬁ cantly more likely to have a 
prespeciﬁ ed amount of improvement as well as a signiﬁ cantly 
greater mean level of improvement in pain on standing and 
pain after walking 50 feet than those randomized to placebo. 
Results of other secondary outcome measures including 
WOMAC pain and function and health-related quality of life 
measured with the SF-12 were not signiﬁ cantly different 
between groups. Another small placebo-controlled trial 
failed to demonstrate a signiﬁ cant beneﬁ t in efﬁ cacy for a 
different commercially available ginger extract.21 Hence, 
there is weak evidence at best to support the efﬁ cacy of 
ginger extract for knee OA.
Fig. 1. Meta-analysis of short-term WOMAC scores, acupuncture compared with sham acupuncture: full analysis and sensitivity analysis
excluding outlying study. Panel A: Pain, Panel B: Function. From reference 11.
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We are currently in the process of conducted a dose-
escalating phase II study of the Chinese herbal compound 
Huo-Luo-Xiao-Ling (HLXL) Dan in patients with knee 
OA; this study is supported by a grant from the National 
Center for Complementary and Alternative Medicine. A 
6-week, phase I multiple dose safety study was conducted 
in seven patients with symptomatic knee OA.22 One patient 
was withdrawn from therapy because of elevated liver 
function tests. There was a signiﬁ cant decline during the 
study period in knee pain as measured with a 10-centimeter 
visual analog scale with differences from baseline reaching 
signiﬁ cance at 3 weeks.
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